On August 21-24, the Precision Medicine Leaders Summit convened key thought leaders from government, academia, the biopharmaceutical industry and the payer and provider communities to discuss advancing the precision medicine field.
At the conference, The Value Collaborative sponsored a panel of distinguished leaders from the diagnostic, academic and patient communities. The discussion, Paying for Personalized Value: New Models for New Science, focused on how to best assess and pay for value in the era of personalized medicine to ensure savings for the health care system as a whole and improved care, outcomes and access for patients.
- Jerry Conway, vice president, Reimbursement & Payer Strategy, Foundation Medicine
- Andrea Ferris, president and chairman of the board, LUNGevity Foundation
- James C. Robinson, Ph.D., director, Berkeley Center for Health Technology, University of California—Berkley
- Gretta Stone, deputy vice president, policy & research, Pharmaceutical Research and Manufacturers of America (PhRMA)